Upgrade to SI Premium - Free Trial

IN8bio, Inc (INAB)

1.45 -0.09 (5.84%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

H.C. Wainwright Reiterates Buy Rating on IN8bio Inc. (INAB) June 4, 2026 6:44 AM - StreetInsider IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies June 3, 2026 8:30 AM - Globe NewsWire IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026 June 1, 2026 8:30 AM - Globe NewsWire Form 8-K IN8BIO, INC. For: May 29 June 1, 2026 6:56 AM - SEC Filing Form 424B5 IN8BIO, INC. June 1, 2026 6:18 AM - SEC Filing Form SCHEDULE 13D/A IN8BIO, INC. Filed by: FAIRBAIRN EMILY May 29, 2026 5:41 PM - SEC Filing Form 4 IN8BIO, INC. For: May 27 Filed by: FAIRBAIRN EMILY May 29, 2026 5:40 PM - SEC Filing Form EFFECT IN8BIO, INC. May 20, 2026 6:04 AM - SEC Filing Form S-3/A IN8BIO, INC. May 18, 2026 5:15 PM - SEC Filing IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma May 14, 2026 8:00 AM - Globe NewsWire Form 4 IN8BIO, INC. For: May 09 Filed by: Epperly Corinne May 12, 2026 4:31 PM - SEC Filing Form 4 IN8BIO, INC. For: May 09 Filed by: Ho William Tai-Wei May 12, 2026 4:31 PM - SEC Filing Form 4 IN8BIO, INC. For: May 09 Filed by: Greenwood Luba May 12, 2026 4:31 PM - SEC Filing Form 4 IN8BIO, INC. For: May 09 Filed by: Lamb Lawrence May 12, 2026 4:31 PM - SEC Filing Form 4 IN8BIO, INC. For: May 09 Filed by: McCall Patrick May 12, 2026 4:31 PM - SEC Filing Form 4 IN8BIO, INC. For: May 09 Filed by: Rochlin Kate May 12, 2026 4:31 PM - SEC Filing Form 4 IN8BIO, INC. For: May 09 Filed by: FAIRBAIRN EMILY May 12, 2026 4:31 PM - SEC Filing Form 4 IN8BIO, INC. For: May 09 Filed by: Brandt Peter C. May 12, 2026 4:31 PM - SEC Filing Form 4 IN8BIO, INC. For: May 09 Filed by: Graff Jeremy R. May 12, 2026 4:31 PM - SEC Filing Form S-8 POS IN8BIO, INC. May 7, 2026 5:23 PM - SEC Filing Form S-8 POS IN8BIO, INC. May 7, 2026 5:22 PM - SEC Filing Form S-8 POS IN8BIO, INC. May 7, 2026 5:21 PM - SEC Filing Form S-8 POS IN8BIO, INC. May 7, 2026 5:21 PM - SEC Filing Form S-8 POS IN8BIO, INC. May 7, 2026 5:20 PM - SEC Filing Form S-8 IN8BIO, INC. May 7, 2026 5:19 PM - SEC Filing Form 10-Q IN8BIO, INC. For: Mar 31 May 7, 2026 4:35 PM - SEC Filing Form 8-K IN8BIO, INC. For: May 07 May 7, 2026 4:33 PM - SEC Filing IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights May 7, 2026 4:30 PM - Globe NewsWire IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences May 6, 2026 8:00 AM - Globe NewsWire RedChip's Biotech Virtual Investor Conference Replays Now Available April 21, 2026 3:00 PM - StreetInsider RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms April 7, 2026 11:00 AM - StreetInsider Jones Trading Assumes IN8bio Inc. (INAB) at Buy April 6, 2026 4:16 PM - StreetInsider IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 3, 2026 4:00 PM - Globe NewsWire Form ARS IN8BIO, INC. For: Dec 31 March 26, 2026 4:10 PM - SEC Filing Form DEFA14A IN8BIO, INC. March 26, 2026 4:09 PM - SEC Filing Form DEF 14A IN8BIO, INC. For: May 07 March 26, 2026 4:06 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on IN8bio Inc. (INAB) March 16, 2026 6:53 AM - StreetInsider Form 10-K IN8BIO, INC. For: Dec 31 March 12, 2026 4:18 PM - SEC Filing Form 8-K IN8BIO, INC. For: Mar 12 March 12, 2026 4:11 PM - SEC Filing IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026 March 12, 2026 4:01 PM - Globe NewsWire Full Article List